Severe inherited thrombophilia includes rare deficiencies of natural anticoagulants
(antithrombin and proteins C and S) and homozygous or combined factor V Leiden and FII …

To review the use of the direct oral anticoagulant (DOAC) agents in inherited thrombophilia
based on the literature. MEDLINE, International Pharmaceutical Abstracts, and Google …

As venous thrombosis is mostly caused by disturbances in the plasma coagulation system,
abnormalities of coagulation factors are mostly risk factors for venous thromboembolism …

Background In this prospective cohort study, we aimed to evaluate the efficacy and safety of
direct oral anticoagulants (DOACs) versus heparin/vitamin K antagonists for the treatment of …

About half of all episodes of venous thromboembolism (VTE, ie deep vein thrombosis and
pulmonary embolism) are elicited by an acquired clinical risk factor, such as recent surgery …

Background Thrombophilia is a condition that predisposes to a higher incidence of venous
thromboembolisms (VTE), some also in atypical sites. Direct oral anticoagulants (DOACs) …

The aim of the study was to investigate whether treatment with non-vitamin K antagonist oral
anticoagulants (NOACs) is effective and well tolerated in real-life patients following venous …

Venous thromboembolism (VTE) is increasingly recognised in primary and secondary care
practice. The arrival of direct oral anticoagulants (DOACs) has made the management of …

Anticoagulant treatment is extremely important and frequently encountered in the therapy of
various cardiovascular diseases. Vitamin K antagonists (VKA) are in use for the prevention …

Thrombophilia is defined as a condition predisposing to the development of venous
thromboembolism (VTE) on the basis of a hypercoagu-lable state. Over the past decades …